These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 14744783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.
    Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A.
    Biochem Biophys Res Commun; 2005 Aug 05; 333(3):1011-6. PubMed ID: 15964556
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.
    Miyamoto S, Nakamura M, Yano K, Ishii G, Hasebe T, Endoh Y, Sangai T, Maeda H, Shi-Chuang Z, Chiba T, Ochiai A.
    Cancer Sci; 2007 May 05; 98(5):685-91. PubMed ID: 17359288
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR, Yang DH, Rosenfeld RG, Oh Y.
    Endocrinology; 2000 Nov 05; 141(11):4171-9. PubMed ID: 11089550
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T, Busby W, Clemmons DR.
    Endocrinology; 1996 Nov 05; 137(11):4571-5. PubMed ID: 8895319
    [Abstract] [Full Text] [Related]

  • 9. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
    Lalou C, Lassarre C, Binoux M.
    Endocrinology; 1996 Aug 05; 137(8):3206-12. PubMed ID: 8754741
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.
    Sadowski T, Dietrich S, Koschinsky F, Sedlacek R.
    Mol Biol Cell; 2003 Nov 05; 14(11):4569-80. PubMed ID: 12937269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activity of human pregnancy insulin-like growth factor binding protein-3: determination by reconstituting recombinant complexes.
    Yan X, Payet LD, Baxter RC, Firth SM.
    Endocrinology; 2009 Nov 05; 150(11):4968-76. PubMed ID: 19734278
    [Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3.
    Kübler B, Draeger C, John H, Andag U, Scharf JG, Forssmann WG, Braulke T, Ständker L.
    FEBS Lett; 2002 May 08; 518(1-3):124-8. PubMed ID: 11997031
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.
    Mañes S, Llorente M, Lacalle RA, Gómez-Moutón C, Kremer L, Mira E, Martínez-A C.
    J Biol Chem; 1999 Mar 12; 274(11):6935-45. PubMed ID: 10066747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.